Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psilocybin program
Recent news which mentions Psilocybin program
< Previous
1
2
Next >
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
April 09, 2024
Tickers
NEWS
OPTHF
Tags
News
Market News
OPTHF
From
Benzinga
Psilocybin Mushrooms For Sale: Is It Legal Anywhere In America?
February 02, 2024
Tickers
CMPS
Tags
Cannabis
Market News
psilocybin therapies
From
Benzinga
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
December 22, 2023
Tickers
IXHL
NEWS
Tags
Clarion Clinics Group
Markets
Cannabis
From
Benzinga
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
December 11, 2023
Tickers
ATAI
BRAXF
CMND
CMPS
Tags
News
ATAI
Penny Stocks
From
Benzinga
Alternative Treatment For Bipolar II Depression: Psilocybin Safe And Effective, AMA Study Finds
December 06, 2023
Tickers
CMPS
Tags
Markets
Market News
Cannabis
From
Benzinga
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Tickers
ATAI
CMND
CMPS
CYBN
Tags
DRUG
MNMD
Benzinga
From
Benzinga
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
November 24, 2023
Tags
MDMA treatment
Psilocybin program
Benzinga
From
Benzinga
Nasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business Combination
November 16, 2023
Tickers
NCAC
Tags
Legal
Management
Psychedelics Financing
From
Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
November 15, 2023
Tickers
AWKNF
CMPS
Tags
Penny Stocks
News
Markets
From
Benzinga
Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market
November 08, 2023
Tickers
PMBHF
Tags
Global
Contracts
Market News
From
Benzinga
COMPASS Pathways Q3 2023 Results: Cash Injection To Sustain Phase 3 Psilocybin Program
November 02, 2023
Tickers
CMPS
Tags
Small Cap
CMPS
Psychedelics
From
Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
November 01, 2023
Tickers
CYBN
Tags
News
Penny Stocks
major depressive disorder
From
Benzinga
EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting
October 26, 2023
Tags
Psychedelics
GMP Certification
Benzinga
From
Benzinga
EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy
September 27, 2023
Tags
News
Exclusives
Apex Labs
From
Benzinga
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
September 21, 2023
Tickers
CYBN
DMTTF
Tags
major depressive disorder
Markets
Market News
From
Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
Tags
Penny Stocks
USPTO
News
From
Benzinga
Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
September 20, 2023
Tags
Cannabis
Market News
Politics
From
Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
Cannabis
ATAI
News
From
Benzinga
Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More
September 07, 2023
Tags
News
Benzinga
Psychedelics
From
Benzinga
Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression
September 06, 2023
Tickers
CMPS
Tags
Psilocybin program
Benzinga
Psychedelics
From
Benzinga
Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows
September 03, 2023
Tags
major depressive disorder
Global
Markets
From
Benzinga
Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance
August 29, 2023
Tickers
TRUFF
Tags
Psychedelic/Assisted Therapies
Psilocybin program
Psychedelics
From
Benzinga
From Ice Rink To Healing Haven: Former NHL Player Sets Up Psilocybin Therapy Center In Colorado
August 25, 2023
Tags
Psychedelics
Benzinga
Psilocybin program
From
Benzinga
Up To $285M In Financing: COMPASS Pathways' Private Placement Backed By 'Select Group' Of Investors
August 16, 2023
Tickers
CMPS
Tags
News
Guidance
Markets
From
Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
August 15, 2023
Tickers
FLHLF
JAQC
Tags
Markets
Cannabis
Market News
From
Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
August 15, 2023
Tickers
MYCOF
Tags
Penny Stocks
News
MYCOF
From
Benzinga
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
August 03, 2023
Tickers
CMPS
HTGC
Tags
CMPS
Small Cap
psychedelic/assisted therapy
From
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Cannabis
LSDI
SILO
From
Benzinga
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player
August 01, 2023
Tickers
MGCLF
OPTHF
TRUFF
Tags
Psychedelic/Assisted Therapies
Psychedelics Import
Psychedelics
From
Benzinga
Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer
August 01, 2023
Tickers
MYCOF
Tags
Psychedelic/Assisted Therapies
Jamaica Psychedelics
Psilocybin program
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.